Company profile: Affera
1.1 - Company Overview
Company description
- Provider of an integrated platform for cardiac arrhythmia treatment delivering durable therapy for a wide range of patients, and pulsed field ablation for atrial fibrillation using a lattice-tip focal catheter.
Products and services
- Integrated Platform for Cardiac Arrhythmia Treatment: Clinical-grade comprehensive system engineered to deliver durable therapy for a wide range of cardiac arrhythmia patients via an integrated platform architecture
- Lattice-tip Focal Catheter: Clinical-grade catheter component featuring a lattice-tip design, employed in pulsed field ablation to treat atrial fibrillation with focal, catheter-based application
- Pulsed Field Ablation: Catheter-guided technique for treating atrial fibrillation using a lattice-tip focal catheter to deliver pulsed-field therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Affera
Longeveron
HQ: United States
Website
- Description: Provider of cellular therapies and research programs, developing Lomecel-B, a culture-expanded medicinal signaling cell (MSC) therapy for aging-related diseases, Alzheimer’s disease, and hypoplastic left heart syndrome (HLHS), with programs testing its use in aging frailty, metabolic syndrome, and acute respiratory distress syndrome (ARDS) due to COVID-19 or influenza.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Longeveron company profile →
Tendyne
HQ: United States
Website
- Description: Provider of clinical-stage, minimally invasive transcatheter therapies focused on treating mitral regurgitation; formed in 2010 and developing its first product concept in transcatheter mitral intervention, as well as a transcatheter aortic valve implantation system.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tendyne company profile →
Tarilian Laser Technologies
HQ: United Kingdom
Website
- Description: Provider of medical technology pioneering an innovative breakthrough in blood pressure monitoring through an unobtrusive wrist-worn wearable device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Tarilian Laser Technologies company profile →
TandemLife
HQ: United States
Website
- Description: Provider of innovative medical device products for cardiologists and cardiac surgeons worldwide, delivering unique solutions for patients requiring circulatory support, including the FDA-cleared TandemHeart System that provides extracorporeal circulatory support in minutes.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TandemLife company profile →
Attgeno
HQ: Sweden
Website
- Description: Provider of pharmaceutical treatments for acute life-threatening conditions, including Supernitro, an intravenous drug for acute pulmonary hypertension that delivers nitric oxide directly to the lungs to reduce pulmonary blood pressure with minimal systemic effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Attgeno company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Affera
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Affera
2.2 - Growth funds investing in similar companies to Affera
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Affera
4.2 - Public trading comparable groups for Affera
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →